Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.

Clinical trial NCT05035212 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05035212
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lower Respiratory Tract Illness

Start date: 2021-08-31
Primary completion: 2027-01-18
Enrollment: 38861

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.